Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea
· Delayed Price · Currency is KRW
9,790.00
-250.00 (-2.49%)
At close: Apr 28, 2026
KOSDAQ:014950 Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Operating Revenue | 60,020 | 55,857 | 51,229 |
| Other Revenue | -0 | -0 | - |
| Revenue | 60,020 | 55,857 | 51,229 |
| Revenue Growth (YoY) | 7.45% | 9.04% | - |
| Cost of Revenue | 17,722 | 17,119 | 17,359 |
| Gross Profit | 42,298 | 38,738 | 33,870 |
| Selling, General & Admin | 36,562 | 32,612 | 28,847 |
| Research & Development | 2,060 | 1,943 | 1,757 |
| Amortization of Goodwill & Intangibles | 5.08 | 25 | 56.12 |
| Other Operating Expenses | 279.95 | 302.34 | 287.89 |
| Operating Expenses | 39,025 | 35,060 | 31,073 |
| Operating Income | 3,273 | 3,678 | 2,796 |
| Interest Expense | -29.22 | -12.26 | -18.53 |
| Interest & Investment Income | 301.52 | 186.69 | 198.16 |
| Currency Exchange Gain (Loss) | 0.92 | 1.75 | 1.36 |
| Other Non Operating Income (Expenses) | -3,893 | 213.21 | 147.23 |
| EBT Excluding Unusual Items | -346.44 | 4,067 | 3,124 |
| Gain (Loss) on Sale of Investments | 348.99 | 300.14 | 298.32 |
| Gain (Loss) on Sale of Assets | 45.98 | 9.5 | 0.07 |
| Asset Writedown | - | -23.8 | - |
| Pretax Income | 48.52 | 4,353 | 3,423 |
| Income Tax Expense | 803.41 | 830.99 | 453.53 |
| Net Income | -754.89 | 3,522 | 2,969 |
| Net Income to Common | -754.89 | 3,522 | 2,969 |
| Net Income Growth | - | 18.62% | - |
| Shares Outstanding (Basic) | 8 | 7 | 7 |
| Shares Outstanding (Diluted) | 8 | 7 | 7 |
| Shares Change (YoY) | 8.46% | 0.15% | - |
| EPS (Basic) | -99.00 | 501.00 | 423.00 |
| EPS (Diluted) | -99.00 | 501.00 | 423.00 |
| EPS Growth | - | 18.44% | - |
| Free Cash Flow | -1,346 | 3,543 | 874.05 |
| Free Cash Flow Per Share | -176.56 | 503.91 | 124.52 |
| Gross Margin | 70.47% | 69.35% | 66.11% |
| Operating Margin | 5.45% | 6.59% | 5.46% |
| Profit Margin | -1.26% | 6.31% | 5.80% |
| Free Cash Flow Margin | -2.24% | 6.34% | 1.71% |
| EBITDA | 4,649 | 5,029 | 4,074 |
| EBITDA Margin | 7.75% | 9.00% | 7.95% |
| D&A For EBITDA | 1,376 | 1,351 | 1,278 |
| EBIT | 3,273 | 3,678 | 2,796 |
| EBIT Margin | 5.45% | 6.59% | 5.46% |
| Effective Tax Rate | 1655.90% | 19.09% | 13.25% |
| Advertising Expenses | 669.39 | 565.36 | 753.43 |
Source: S&P Capital IQ. Standard template.
Financial Sources.